SEC Delays Approval of Nasdaq PHLX’s Bitcoin Index Options
The Securities and Exchange Commission (SEC) has decided to delay the approval of Nasdaq PHLX’s proposed Bitcoin index options. This decision follows the agency’s agreement to the CME Group’s request for a full review of the situation, which was formally acknowledged in a July 29 order. The official notice of this ruling was published in the Federal Register on August 3, thereby establishing August 24 as the cutoff date for stakeholders to submit written comments either in favor of or against the previous approval granted on May 22.
Details of the Proposed Index Options
This recent order does not address the validity of the CME’s jurisdictional challenge, which is centered around Bitcoin’s classification as a commodity, leaving the previous approval on pause until further notice from the Commission.
The proposed index options, known as QBTC, are designed to be cash-settled and take on a European-style format. They would be linked to the CME CF Bitcoin Real Time Index, with final settlements based on the CME CF Bitcoin Reference Rate, both adjusted to a scale of 100. The proposed regulatory framework includes limits on contract positions, specifying a cap of 24,000 contracts. Unlike options tied to Bitcoin Exchange-Traded Fund (ETF) shares, QBTC’s framework will focus directly on Bitcoin’s value, presenting significant legal differences since ETF shares are categorized as securities while Bitcoin is treated under federal laws as a commodity.
CME Group’s Appeal and Concerns
CME Group initiated its appeal on June 11, shortly after the SEC staff granted approval for these rules, effectively halting actions on the decision. In its formal petition, submitted on June 18, CME contends that Bitcoin should be recognized as a commodity, asserting that any derivatives based on its value should fall under the jurisdiction of the Commodity Futures Trading Commission (CFTC) rather than the SEC. CME’s officials have claimed that the SEC’s prior review process was flawed, suggesting that the agency exceeded its authority when it approved the option contracts.
The CME has raised concerns that if the SEC’s approval is enacted, it could lead to increased regulatory burdens for its exchanges and impact its competitive stance. The group has urged that the approval be withdrawn rather than wait for the CFTC’s separate exemptions process. In contrast, the SEC’s initial approval leaned on the interpretation of the Dodd-Frank Act‘s provisions, suggesting that dual oversight could be permissible under certain conditions set by the CFTC.
Next Steps for Nasdaq and Implications
While the SEC’s approval has been a necessary step, it does not provide a complete foundation for starting trading activities. Nasdaq must still seek necessary exemptions from the CFTC and secure approvals from the Options Clearing Corporation (OCC) to clear the contracts without needing to register as a derivatives clearing organization, including updating its options risk disclosures.
Despite the current standstill, Nasdaq has been enhancing its cryptocurrency offerings, collaborating with Pyth to supply exchange order-book data and pursuing partnerships for crypto index futures covering various digital currencies. This dispute focuses narrowly on the options that directly relate to Bitcoin and excludes broader perspectives concerning Bitcoin ETFs.
Interested parties have until August 24 to weigh in with their positions on the SEC’s decision. Following this evaluation, the Commission will decide whether to uphold the initial approval. However, no specific timeline has been established for a conclusive ruling from the SEC on this matter. The implications of this case could extend beyond just QBTC, as CME cautions it may pave the way for securities exchanges to list derivatives based on other commodities, although this remains a speculative legal argument rather than a definitive conclusion reached by the Commission.
